covering transdermal-patch administration of the narcotic painkiller fentanyl is infringed by Mylan Laboratories, not invalid and not unenforceable. On appeal, Mylan argued that the claims were ...

Application of a multi-stacked fentanyl patch could result in serious, life-threatening, or fatal respiratory depression.

The U.S. Food and Drug Administration announced last week that a pharmaceutical company is removing a fentanyl patch from ...

AVERSA Fentanyl has the potential to be the world’s first abuse-deterrent opioid patch designed to deter the abuse and misuse and reduce the risk of accidental exposure of transdermal fentanyl ...

Mikayla Brown and her husband, Tyler, visit the grave of their son, Elijah, who died of a fentanyl overdose at ...

Nutriband and Kindeva formalize exclusive product development partnership and long-term commitment based on shared development costs in exchange ...

Aversa Fentanyl holds the potential to become the world’s first abuse-deterrent opioid patch.

Alvogen Inc. is recalling 1 lot of Fentanyl Transdermal System 25mcg/h transdermal patches due to the potential for multi-stacked patches (adhered one on top of the other) in a single product pouch.

Alvogen has issued a voluntary recall on a single lot of fentanyl transdermal patches due to the risk that some of the products could be "multi-stacked" and stuck together in a single pouch.

Alvogen has issued a nationwide recall of one lot of Fentanyl Transdermal System 25 patches because the patches may stick ...